--- title: "Madrigal制药 (MDGL.US) — 财务报表" type: "Symbol" locale: "zh-CN" url: "https://longbridge.com/zh-CN/quote/MDGL.US/norm.md" symbol: "MDGL.US" name: "Madrigal制药" parent: "https://longbridge.com/zh-CN/quote/MDGL.US.md" datetime: "2026-05-20T06:54:04.059Z" locales: - [en](https://longbridge.com/en/quote/MDGL.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/MDGL.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/MDGL.US/norm.md) --- # Madrigal制药 (MDGL.US) — 财务报表 ## 利润表 (USD) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 每股收益 | -3.25 | -2.57 | -5.08 | -1.90 | -2.61 | | ROE | -65.88% | -38.15% | -69.12% | -24.05% | -39.99% | | 营业收入 | 311.34M | 321.08M | 287.27M | 212.80M | 137.25M | | 净利润 | -94.39M | -58.58M | -114.19M | -42.28M | -73.24M | | 营业利润 | -92.72M | -59.61M | -113.97M | -47.20M | -79.31M | | 毛利率 | 91.38% | 92.39% | 93.69% | 95.74% | 96.71% | | 净利率 | -30.32% | -18.24% | -39.75% | -19.87% | -53.36% | | 利润含金量 | - | - | -142.74% | - | - | ## 资产负债表 (USD) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 资产与负债 | 1.23B | 1.26B | 1.36B | 1.02B | 996.63M | | 权益乘数 | 2.26 | 2.09 | 2.18 | 1.46 | 1.40 | | 每股净资产 | 23.59 | 26.39 | 27.56 | 31.32 | 32.03 | | 资产周转率 | 1.02 | 0.8327 | 0.6081 | 0.4875 | 0.3053 | | 现金及短投 | 812.77M | 983.56M | 1.11B | 797.02M | 843.07M | | 存货与应收 | 112.07M | 74.84M | 69.32M | 63.50M | 55.24M | | 长期投资 | 14.24M | 6.44M | 8.30M | 7.48M | 4.01M | | 净债务 | -465.46M | -635.93M | -763.35M | -673.08M | -723.30M | ## 现金流量表 (USD) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 经营现金流 | -167.44M | -133.46M | 79.85M | -47.05M | -88.89M | | 投资现金流 | 192.19M | 27.58M | -207.00M | 47.86M | 163.88M | | 融资现金流 | 2.33M | 8.96M | 236.65M | 1.74M | 8.64M | | 自由现金流 | -107.02M | -115.47M | 117.34M | -36.10M | -68.51M | | 现金流充裕率 | -4350.09% | 34220.51% | 65.17% | - | - | | 举债与偿债 | - | 0.0000 | 350.00M | - | - | | 资本支出 | -3.85M | 390000.00 | -857000.00 | - | - |